About Kantil Formulations Private Limited
Data last updated:
Kantil Formulations Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 February 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2022PTC393790.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Nitin Gupta and Sachin Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 5 Raj Nagar Pitampura, Delhi, India – 110034.
For more details, the company can be reached via its website kantil.in.
Company details
Contact details
Kantil Formulations Private Limited's registered office is in Delhi, Delhi.
- Social Media
- Registered Address5 Raj Nagar Pitampura, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Kantil Formulations Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Kantil Formulations Private Limited, buy the company report.
Board of directors of Kantil Formulations Private Limited
Kantil Formulations has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nitin Gupta Also directs: Avecia Biological LLP, Shinit Ventures LLP, Integra Health International LLP and 1 more | Director | 12 Feb 2022 | 4 Years 8 Months | Current |
| Sachin Gupta | Director | 12 Feb 2022 | 4 Years 8 Months | Current |
| Sarika Gupta Also directs: Kantil Pharmaceuticals Private Limited | Director | 15 Mar 2023 | 3 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Kantil Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kantil Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Kantil Formulations Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Kantil Formulations Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Sarika Gupta was appointed as Director on 15 Mar 2023.
Frequently asked questions
Kantil Formulations is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 February 2022 (4+ years old) and is registered under CIN U24290DL2022PTC393790.
Kantil Formulations has 3 current directors:
- Nitin Gupta - Director
- Sachin Gupta - Director
- Sarika Gupta - Director
The latest financial statements of Kantil Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Kantil Formulations is U24290DL2022PTC393790. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kantil Formulations was incorporated on 12 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
Sarika Gupta was appointed as Director on 15 Mar 2023. Nitin Gupta was appointed as Director on 12 Feb 2022. Sachin Gupta was appointed as Director on 12 Feb 2022.
Kantil Formulations can be reached through the website kantil.in. Its registered office is in Delhi, India.
The registered office of Kantil Formulations is at 5 Raj Nagar Pitampura, Delhi, India – 110034.
Kantil Formulations operates in the pharma industry, in the drug formulation and development segment.
Kantil Formulations is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
